Paper microfluidic implementation of loop mediated isothermal amplification for early diagnosis of hepatitis C virus.
Weronika Witkowska McConnellChris DavisSuleman R SabirAlice GarrettAmanda Bradley-StewartPawel JajesniakJulien ReboudGaolian XuZhugen YangRory GunsonEmma C ThomsonJonathan M CooperPublished in: Nature communications (2021)
The early diagnosis of active hepatitis C virus (HCV) infection remains a significant barrier to the treatment of the disease and to preventing the associated significant morbidity and mortality seen, worldwide. Current testing is delayed due to the high cost, long turnaround times and high expertise needed in centralised diagnostic laboratories. Here we demonstrate a user-friendly, low-cost pan-genotypic assay, based upon reverse transcriptase loop mediated isothermal amplification (RT-LAMP). We developed a prototype device for point-of-care use, comprising a LAMP amplification chamber and lateral flow nucleic acid detection strips, giving a visually-read, user-friendly result in <40 min. The developed assay fulfils the current guidelines recommended by World Health Organisation and is manufactured at minimal cost using simple, portable equipment. Further development of the diagnostic test will facilitate linkage between disease diagnosis and treatment, greatly improving patient care pathways and reducing loss to follow-up, so assisting in the global elimination strategy.
Keyphrases
- loop mediated isothermal amplification
- hepatitis c virus
- low cost
- nucleic acid
- human immunodeficiency virus
- sensitive detection
- high throughput
- healthcare
- primary care
- public health
- mental health
- circulating tumor cells
- quality improvement
- climate change
- men who have sex with men
- hiv testing
- risk assessment
- combination therapy
- smoking cessation
- replacement therapy